DH Private Equity Partners:企業の戦略・SWOT・財務分析

◆英語タイトル:DH Private Equity Partners - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4052
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

DH Private Equity Partners – Strategy, SWOT and Corporate Finance Report
Summary

DH Private Equity Partners – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DH Private Equity Partners (DH) is a private equity company. The company makes investments in private equity, real estate, and technology ventures portfolios. It provides support services in the area of investment strategy, portfolio management, investment advisory and consultancy, operational developments, strategic expansion, and value enhancement. It acquires and invests in mid-market businesses and leveraged buyouts and buy-ins. DH operates through a network of offices and has developed a strong relationship with the advisors and owners of industrial operations and businesses in Europe. The company’s investment portfolio includes investment in diversified geographies including North America, the UK, Middle East, Asia Pacific, and Europe region. DH is headquartered in London, the UK.

Scope

- Detailed information on DH Private Equity Partners required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DH Private Equity Partners in the form of a SWOT analysis
- An in-depth view of the business model of DH Private Equity Partners including a breakdown and examination of key business segments
- Intelligence on DH Private Equity Partners’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DH Private Equity Partners, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DH Private Equity Partners and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DH Private Equity Partners as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DH Private Equity Partners’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
DH Private Equity Partners: Company Overview
DH Private Equity Partners: Overview and Key Facts
DH Private Equity Partners: Overview
DH Private Equity Partners: Key Facts
DH Private Equity Partners: Key Employees
DH Private Equity Partners: Key Employee Biographies
DH Private Equity Partners: Major Products and Services
DH Private Equity Partners: Company History
DH Private Equity Partners: Key Competitors
DH Private Equity Partners: Company Analysis
DH Private Equity Partners: Business Description
DH Private Equity Partners: SWOT Analysis
DH Private Equity Partners: SWOT Overview
DH Private Equity Partners: Strengths
DH Private Equity Partners: Weaknesses
DH Private Equity Partners: Opportunities
DH Private Equity Partners: Threats
DH Private Equity Partners: Corporate Financial Deals Activity
DH Private Equity Partners: Financial Deals Overview
DH Private Equity Partners: Top Deals 2016 – 2020YTD*
DH Private Equity Partners: Advisors
DH Private Equity Partners: Top Legal Advisors
DH Private Equity Partners: Divestments
DH Private Equity Partners: Recent Developments
DH Private Equity Partners: News and Events Summary
DH Private Equity Partners: Financial Performance
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: DH Private Equity Partners: Key Facts
Table 2: DH Private Equity Partners: Key Employees
Table 3: DH Private Equity Partners: Company History
Table 4: DH Private Equity Partners: Key Competitors
Table 5: DH Private Equity Partners: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 6: DH Private Equity Partners: Top Deals 2016 - 2020YTD*
Table 7: DH Private Equity Partners: Legal Advisor Ranking by Value (US$m)
Table 8: DH Private Equity Partners: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 9: DH Private Equity Partners: Divestments by Geography (2016 - YTD*2020)
Table 10: DH Private Equity Partners: News and Events Summary
Table 11: DH Private Equity Partners: Financial Performance

★海外企業調査レポート[DH Private Equity Partners:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Heptares Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Heptares Therapeutics Ltd (Heptares) a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise S …
  • Yifan Pharmaceutical Co.,Ltd:企業の戦略・SWOT・財務情報
    Yifan Pharmaceutical Co.,Ltd - Strategy, SWOT and Corporate Finance Report Summary Yifan Pharmaceutical Co.,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ali Baba:企業の戦略・SWOT・財務情報
    Ali Baba - Strategy, SWOT and Corporate Finance Report Summary Ali Baba - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • Takara Holdings Inc.:企業の戦略・SWOT・財務分析
    Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Daechang Forging Co Ltd
    Daechang Forging Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daechang Forging Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tanita Corp:企業の戦略的SWOT分析
    Tanita Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Mundipharma International Ltd:企業の戦略的SWOT分析
    Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • PT. Indonesia Power:企業の戦略的SWOT分析
    PT. Indonesia Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company that discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company provides product portfolio such as encompasses investigational candidates in preclinical trials: peptide-sm …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • China Petroleum & Chemical Corp (600028):電力:M&Aディール及び事業提携情報
    Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and production …
  • Kingfisher Plc:戦略・SWOT・企業財務分析
    Kingfisher Plc - Strategy, SWOT and Corporate Finance Report Summary Kingfisher Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Umecrine Cognition AB-製薬・医療分野:企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …
  • Haitong Securities Co., Ltd.:企業のM&A・事業提携・投資動向
    Haitong Securities Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Haitong Securities Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Salt Lake Potash Ltd (SO4):企業の財務・戦略的SWOT分析
    Summary Salt Lake Potash Ltd (Salt Lake Potash), formerly Wildhorse Energy Ltd, is a mining and mineral exploration and development company that develops and evaluates underground coal gasification projects and uranium deposits. The company operates exploration and mining activities with geographic …
  • Sequa Petroleum NV:石油・ガス:M&Aディール及び事業提携情報
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company that develops, acquires, monetises, produces and finances oil and natural gas assets. The company holds assets in Kazakhstan, North Western Europe and Sub Saharan Africa. Its Kazakhstan exploration site is located in Aksai block …
  • AB-Biotics SA (ABB):医療機器:M&Aディール及び事業提携情報
    Summary AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprieta …
  • Concord Medical Services Holdings Ltd (CCM):製薬・医療:M&Aディール及び事業提携情報
    Summary Concord Medical Services Holdings Ltd (CMS) is a diagnostic imaging center that offers clinical support services and laboratory services. The center offers radiotherapy and diagnostic imaging equipment services such as head gamma knife systems, body gamma knife systems and linear accelerator …
  • Cohera Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Cohera Medical Inc (Cohera) is a medical device company that designs and develops surgical adhesives and sealants. The company’s products include TissuGlu surgical adhesive, and Sylys surgical sealant. Its TissuGlu surgical adhesive is biocompatible for internal use, and forms a bond between …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆